Stock listing

ACW Stock Price, News, Filings & Events — Actinogen Medical Limited

Selected listing: ACW · ASX · AUD · AU

This page tracks Actinogen Medical Limited's ACW:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACW:ASX. ACW:ASX is the stock-level entry point for investors researching Actinogen Medical Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Actinogen Medical Limited (Ticker: ACW) is a public company based in Australia with a market capitalization of approximately AUD 106.6 million. The company focuses on developing innovative treatments for cognitive disorders. Actinogen is committed to advancing its research and clinical programs to address significant unmet medical needs in this area.

ACW:ASXAUDAUUpdated September 11, 2026
Actinogen Medical Limited logo
Ticker
ACW:ASX
Asset type
Stock
Market cap
$157.8M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
ASX
Currency
AUD

Actinogen Medical Limited ACW:ASX stock context

This page tracks Actinogen Medical Limited's ACW:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACW:ASX. ACW:ASX is the stock-level entry point for investors researching Actinogen Medical Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Actinogen Medical Limited (Ticker: ACW) is a public company based in Australia with a market capitalization of approximately AUD 106.6 million. The company focuses on developing innovative treatments for cognitive disorders. Actinogen is committed to advancing its research and clinical programs to address significant unmet medical needs in this area.

Latest news from Actinogen Medical Limited

All Actinogen Medical Limited news →

Research Actinogen Medical Limited

Alternate listings